<DOC>
	<DOCNO>NCT01043367</DOCNO>
	<brief_summary>The purpose study assess efficacy DEPREXIL administration combination relaxation psychotherapy treatment patient sign symptom depression . The duration double-blind placebo control phase 3 clinical trial 24 week . The estimated number person recruit randomize study 200 .</brief_summary>
	<brief_title>Deprexil Subjects With Signs Symptoms Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<criteria>Mild moderate symptom sign depression 3 month le 3 year duration . Signed informed consent Severe symptoms sign depression Suicide proneness . Pregnancy breastfeed Receiving experimental drug Use antidepressive medication within 15 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Depression</keyword>
	<keyword>Dietary supplement</keyword>
	<keyword>Deprexil</keyword>
</DOC>